Cargando…
An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease
Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves’ thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if p...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538055/ https://www.ncbi.nlm.nih.gov/pubmed/28781829 http://dx.doi.org/10.1002/ccr3.1022 |